SEARCH

SEARCH BY CITATION

References

  • 1
    BousquetJ, LockeyR, MallingHJ (editors). World Health Organization position paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53(Suppl. 54):514.
  • 2
    Malling HJ. Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol 2001;1:4346.
  • 3
    Abramson MJ, Puy RM, Weiner J. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;(4):CD001186.
  • 4
    Wilson DM, Torres Lima I, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003;(4):CD002893 (review).
  • 5
    Committee on the safety of medicines. CSM update. Desensitizing vaccines. Br Med J 1986;293:948.
  • 6
    Reid MJ, Lockey RF, Turkeltaub PC, Platt-Mills TAE. Survey of fatalities from skin testing and immunotherapy. J Allergy Clin Immunol 1993;92:615.
  • 7
    Canonica GW, Passalacqua G. Non injection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437448.
  • 8
    BousquetJ, Van CauwenbergeP (editors). Allergic Rhinits and its Impact on Asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):S146S333.
  • 9
    Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998;351:629632.
  • 10
    Mortemousque B, Bertel F, De Casamayor J, Verin P, Colin J. House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 2003;33:464469.
  • 11
    Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study. Allergy 1999;54:249260.
  • 12
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498504.
  • 13
    Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(Suppl. 1):S45S53.
  • 14
    Baiardini I, Pasquali M, Giardini A, Majani G, Canonica GW. Quality of life in respiratory allergy. Allergy Asthma Proc 2001;22:177181.
  • 15
    Majani G, Baiardini I, D'Ulisse S, Canonica GW. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001;56:313317.
  • 16
    Majani G, Callegari S, Pierobon A, Giardini A, Viola L, Baiardini I et al. A new instrument in quality of life assessment: the Satisfaction Profile. Int J Ment Health 1999;28:7782.
  • 17
    GINA. Global Initiative on Asthma. Guidelines, 2005. http://www.ginasthma.com
  • 18
    DreborgS (editor). EAACI subcommittee on skin tests. Skin tests used in type I allergy testing. Position paper. Allergy 1989;44(Suppl. 10):2231.
  • 19
    Mistrello G, Brenna O, Roncarolo D, Zanoni D, Gentili M, Falagiani P. Monomeric chemically modified allergens: immunologic and physicochemical characterization. Allergy 1996;51:815.
  • 20
    Baiardini I, Giardini A, Pasquali M, Dignetti P, Guerra L, Specchia C et al. Quality of life and patient's satisfaction in chronic urticaria and respiratory allergy. Allergy 2003;58:621623.
  • 21
    Apolone G, Moscone P, Ware JE. Questionario Sullo Stato Di Salute SF-36. Manuale D'uso Ed Interpretazione Dei Risultati. Milan: Guerini, 1997.
  • 22
    Majani G, Baiardini I, Giardini A, Senna GE, Minale P, D'Ulisse S et al. Quality of life assessment in young adults with seasonal allergic rhinitis during and after the pollen season. Allergy 2001;56:313317.
  • 23
    Leynaert BJ, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in non atopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301304.
  • 24
    Proceedings from Assemblea Generale Ordinaria Dei Partecipanti. Roma: Banca D'Italia, 2003.
  • 25
    Ippoliti F, De Sanctis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216221.
  • 26
    Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunological effects of longterm sublingual immunotherapy in asthmatic children sensitized to mite: a double blind study. Allergy 2000;55:842849.
  • 27
    Hirsch T, Sahn M, Leupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extracts in children. Pediatr Allergy Immunol 1997;8:2127.
  • 28
    Guez S, Vatrinet C, Fadel R, Andre’ C. House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double blind placebo controlled study. Allergy 2000;55:369375.
  • 29
    Kremer B, Klimek L, Bullinger M, Mosges R. Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? Allergy 2001;56:957963.
  • 30
    Lombardi C, Gani F, Landi M, Falagiani P, Bruno M, Canonica GW et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004;113:12191220.
  • 31
    Di Rienzo V, Musarra A, Sambugaro R, Minelli M, Pecora S, Canonica GW et al. Post marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005;35:560564.
  • 32
    Bagnasco M, Altrinetti V, Pesce G, Caputo M, Mistrello G, Falagiani P et al. Pharmacokinetics of radiolabelled Der p 2 allergen and monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005;138:197202.